These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24454895)

  • 21. Toll-like receptor-5 agonist, entolimod, suppresses metastasis and induces immunity by stimulating an NK-dendritic-CD8+ T-cell axis.
    Brackett CM; Kojouharov B; Veith J; Greene KF; Burdelya LG; Gollnick SO; Abrams SI; Gudkov AV
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E874-83. PubMed ID: 26831100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toll-like receptor 5 engagement modulates tumor development and growth in a mouse xenograft model of human colon cancer.
    Rhee SH; Im E; Pothoulakis C
    Gastroenterology; 2008 Aug; 135(2):518-28. PubMed ID: 18538140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous targeting of toll- and nod-like receptors induces effective tumor-specific immune responses.
    Garaude J; Kent A; van Rooijen N; Blander JM
    Sci Transl Med; 2012 Feb; 4(120):120ra16. PubMed ID: 22323829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis of TLR5-flagellin recognition and signaling.
    Yoon SI; Kurnasov O; Natarajan V; Hong M; Gudkov AV; Osterman AL; Wilson IA
    Science; 2012 Feb; 335(6070):859-64. PubMed ID: 22344444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of the TLR5 agonist CBLB502 and its downstream effector IL-22 against liver injury.
    Melin N; Sánchez-Taltavull D; Fahrner R; Keogh A; Dosch M; Büchi I; Zimmer Y; Medová M; Beldi G; Aebersold DM; Candinas D; Stroka D
    Cell Death Dis; 2021 Apr; 12(4):366. PubMed ID: 33824326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR5 functions as an endocytic receptor to enhance flagellin-specific adaptive immunity.
    Letran SE; Lee SJ; Atif SM; Uematsu S; Akira S; McSorley SJ
    Eur J Immunol; 2011 Jan; 41(1):29-38. PubMed ID: 21182074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice.
    Sharma P; Levy O; Dowling DJ
    Front Immunol; 2020; 11():171. PubMed ID: 32132997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5.
    Hayashi F; Smith KD; Ozinsky A; Hawn TR; Yi EC; Goodlett DR; Eng JK; Akira S; Underhill DM; Aderem A
    Nature; 2001 Apr; 410(6832):1099-103. PubMed ID: 11323673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flagellin increases death receptor-mediated cell death in a RIP1-dependent manner.
    Hancz D; Szabo A; Molnar T; Varga Z; Hancz A; Gregus A; Hueber AO; Rajnavolgyi E; Koncz G
    Immunol Lett; 2018 Jan; 193():42-50. PubMed ID: 29175315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptor 5 is not essential for the promotion of secretory immunoglobulin A antibody responses to flagellated bacteria.
    Hashizume-Takizawa T; Yamamoto M
    Microbiol Immunol; 2015 Dec; 59(12):716-23. PubMed ID: 26564803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amino acids 89-96 of Salmonella typhimurium flagellin represent the major domain responsible for TLR5-independent adjuvanticity in the humoral immune response.
    Zhang L; Pan Z; Kang X; Yang Y; Kang H; Zhang N; Rosati JM; Jiao X
    Cell Mol Immunol; 2015 Sep; 12(5):625-32. PubMed ID: 25195514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial flagellin stimulates Toll-like receptor 5-dependent defense against vancomycin-resistant Enterococcus infection.
    Kinnebrew MA; Ubeda C; Zenewicz LA; Smith N; Flavell RA; Pamer EG
    J Infect Dis; 2010 Feb; 201(4):534-43. PubMed ID: 20064069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor 5-mediated signaling enhances liver regeneration in mice.
    Zhang W; Wang L; Sun XH; Liu X; Xiao Y; Zhang J; Wang T; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Ren GM; Yin RH; Yang XM
    Mil Med Res; 2021 Feb; 8(1):16. PubMed ID: 33622404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of adaptive immunity by flagellin does not require robust activation of innate immunity.
    Sanders CJ; Franchi L; Yarovinsky F; Uematsu S; Akira S; Núñez G; Gewirtz AT
    Eur J Immunol; 2009 Feb; 39(2):359-71. PubMed ID: 19152336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin.
    Vijay-Kumar M; Carvalho FA; Aitken JD; Fifadara NH; Gewirtz AT
    Eur J Immunol; 2010 Dec; 40(12):3528-34. PubMed ID: 21072873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.
    Chalifour A; Jeannin P; Gauchat JF; Blaecke A; Malissard M; N'Guyen T; Thieblemont N; Delneste Y
    Blood; 2004 Sep; 104(6):1778-83. PubMed ID: 15166032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bacterial flagellin, Vibrio vulnificus FlaB, has a strong mucosal adjuvant activity to induce protective immunity.
    Lee SE; Kim SY; Jeong BC; Kim YR; Bae SJ; Ahn OS; Lee JJ; Song HC; Kim JM; Choy HE; Chung SS; Kweon MN; Rhee JH
    Infect Immun; 2006 Jan; 74(1):694-702. PubMed ID: 16369026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion of Bacterial Flagellin to a Dendritic Cell-Targeting αCD40 Antibody Construct Coupled With Viral or Leukemia-Specific Antigens Enhances Dendritic Cell Maturation and Activates Peptide-Responsive T Cells.
    Schmitt S; Tahk S; Lohner A; Hänel G; Maiser A; Hauke M; Patel L; Rothe M; Josenhans C; Leonhardt H; Griffioen M; Deiser K; Fenn NC; Hopfner KP; Subklewe M
    Front Immunol; 2020; 11():602802. PubMed ID: 33281829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New malaria vaccine candidates based on the Plasmodium vivax Merozoite Surface Protein-1 and the TLR-5 agonist Salmonella Typhimurium FliC flagellin.
    Bargieri DY; Rosa DS; Braga CJ; Carvalho BO; Costa FT; Espíndola NM; Vaz AJ; Soares IS; Ferreira LC; Rodrigues MM
    Vaccine; 2008 Nov; 26(48):6132-42. PubMed ID: 18804504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like Receptor Agonist CBLB502 Protects Against Cisplatin-induced Liver and Kidney Damage in Mice.
    Niu P; Zhao W; Wang Q; Duan J; Zhu J; Fu H; Wu Y; Zheng X; Zhang D; Ge C
    In Vivo; 2023; 37(5):2044-2056. PubMed ID: 37652484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.